Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6262 ARTÍCULOS , VIENDO DEL 5026 AL 5040

Smartphone applications for Movement Disorders: Towards collaboration and re-use

Willemse IHJ, Schootemeijer S, van den Bergh R, Dawes H, Nonnekes JH, van de Warrenburg BPC.

Parkinsonism Relat Disord. 2024 Mar;120:105988. doi: 10.1016/j.parkreldis.2023.105988. Epub 2024 Jan 1.

Chorea - Is Diabetes Mellitus the Cause?

Phan T, Klouda E, Jackson CD.

J Gen Intern Med. 2024 Sep;39(12):2347-2350. doi: 10.1007/s11606-024-08666-1. Epub 2024 Jun 17.

Mechanistic insights on TLR-4 mediated inflammatory pathway in neurodegenerative diseases

Sharma V, Sharma P, Singh TG.

Pharmacol Rep. 2024 Aug;76(4):679-692. doi: 10.1007/s43440-024-00613-5. Epub 2024 Jun 25.

miR-196a in the carcinogenesis and other disorders with an especial focus on its biomarker capacity

Khalilian S, Hosseini Imani SZ, Abedinlou H, Omrani MA, Ghafouri-Fard S.

Pathol Res Pract. 2024 Aug;260:155433. doi: 10.1016/j.prp.2024.155433. Epub 2024 Jun 30.

Comparing balance using the BESTest in Alzheimer, Huntington and Parkinson disease

Tueth LE, Duncan RP, Crowner BE, Earhart GM.

Neurodegener Dis Manag. 2024;14(3-4):87-96. doi: 10.1080/17582024.2024.2388507. Epub 2024 Aug 19.

Imidazoline receptors as a new therapeutic target in Huntington's disease: A preclinical overview

Jari S, Ratne N, Tadas M, Katariya R, Kale M, Umekar M, Taksande B.

Ageing Res Rev. 2024 Nov;101:102482. doi: 10.1016/j.arr.2024.102482. Epub 2024 Sep 3.

HAT and HDAC: Enzyme with Contradictory Action in Neurodegenerative Diseases

Singh R, Rathore AS, Dilnashin H, Keshri PK, Gupta NK, Prakash SAS, Zahra W, Singh S, Singh SP.

Mol Neurobiol. 2024 Nov;61(11):9110-9124. doi: 10.1007/s12035-024-04115-6. Epub 2024 Apr 8.

Unlocking the epigenetic symphony: histone acetylation's impact on neurobehavioral change in neurodegenerative disorders

Basavarajappa BS, Subbanna S.

Epigenomics. 2024 Mar;16(5):331-358. doi: 10.2217/epi-2023-0428. Epub 2024 Feb 7.

Navigating the Frontiers of Machine Learning in Neurodegenerative Disease Therapeutics

Cha Y, Kagalwala MN, Ross J.

Pharmaceuticals (Basel). 2024 Jan 25;17(2):158. doi: 10.3390/ph17020158.

Gangliosides as Therapeutic Targets for Neurodegenerative Diseases

Inci OK, Basırlı H, Can M, Yanbul S, Seyrantepe V.

J Lipids. 2024 Apr 8;2024:4530255. doi: 10.1155/2024/4530255. eCollection 2024.

Dual-Task Assessments for Predicting Future Falls in Neurologic Conditions: A Systematic Review

Peters J, Lauinger A, Mayr M, Ginell K, Abou L.

Am J Phys Med Rehabil. 2024 Jun 1;103(6):554-560. doi: 10.1097/PHM.0000000000002452. Epub 2024 Feb 29.

Neuroinflammatory Proteins in Huntington's Disease: Insights into Mechanisms, Diagnosis, and Therapeutic Implications

Li X, Tong H, Xu S, Zhou G, Yang T, Yin S, Yang S, Li X, Li S.

Int J Mol Sci. 2024 Nov 2;25(21):11787. doi: 10.3390/ijms252111787.

Current understanding and future directions of cruciferous vegetables and their phytochemicals to combat neurological diseases

Kakarla R, Karuturi P, Siakabinga Q, Kasi Viswanath M, Dumala N, Guntupalli C, Nalluri BN, Venkateswarlu K, Prasanna VS, Gutti G, Yadagiri G, Gujjari L.

Phytother Res. 2024 Mar;38(3):1381-1399. doi: 10.1002/ptr.8122. Epub 2024 Jan 12.

Regulation of HTT mRNA Biogenesis: The Norm and Pathology

Zubkova AE, Yudkin DV.

Int J Mol Sci. 2024 Oct 26;25(21):11493. doi: 10.3390/ijms252111493.

Targeting ferroptosis in neuroimmune and neurodegenerative disorders for the development of novel therapeutics

Li Z, Zhang Y, Ji M, Wu C, Zhang Y, Ji S.

Biomed Pharmacother. 2024 Jul;176:116777. doi: 10.1016/j.biopha.2024.116777. Epub 2024 May 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias